Bifogade filer
Kurs
+0,10%
Likviditet
2,00 MSEK
Kalender
Tid* | ||
2025-02-20 | 07:00 | Bokslutskommuniké 2024 |
2024-11-11 | - | Kvartalsrapport 2024-Q3 |
2024-10-11 | - | 15-6 2024 |
2024-09-30 | - | Extra Bolagsstämma 2024 |
2024-08-13 | - | Kvartalsrapport 2024-Q2 |
2024-06-17 | - | Årsstämma |
2024-05-23 | - | Kvartalsrapport 2024-Q1 |
2024-05-14 | - | X-dag ordinarie utdelning CALTX 0.00 SEK |
2024-05-13 | - | Årsstämma |
2024-02-21 | - | Bokslutskommuniké 2023 |
2023-11-07 | - | Kvartalsrapport 2023-Q3 |
2023-08-17 | - | Kvartalsrapport 2023-Q2 |
2023-05-30 | - | Årsstämma |
2023-05-25 | - | Årsstämma |
2023-05-19 | - | X-dag ordinarie utdelning CALTX 0.00 SEK |
2023-05-16 | - | Kvartalsrapport 2023-Q1 |
2023-02-23 | - | Bokslutskommuniké 2022 |
2022-11-14 | - | Kvartalsrapport 2022-Q3 |
2022-08-18 | - | Kvartalsrapport 2022-Q2 |
2022-05-20 | - | X-dag ordinarie utdelning CALTX 0.00 SEK |
2022-05-19 | - | Årsstämma |
2022-05-18 | - | Kvartalsrapport 2022-Q1 |
2022-02-24 | - | Bokslutskommuniké 2021 |
2021-11-18 | - | Kvartalsrapport 2021-Q3 |
2021-08-19 | - | Kvartalsrapport 2021-Q2 |
2021-05-27 | - | Årsstämma |
2021-05-13 | - | Kvartalsrapport 2021-Q1 |
2021-05-03 | - | X-dag ordinarie utdelning CALTX 0.00 SEK |
2021-02-18 | - | Bokslutskommuniké 2020 |
2020-11-12 | - | Kvartalsrapport 2020-Q3 |
2020-08-13 | - | Kvartalsrapport 2020-Q2 |
2020-06-26 | - | X-dag ordinarie utdelning CALTX 0.00 SEK |
2020-06-25 | - | Årsstämma |
2020-05-14 | - | Kvartalsrapport 2020-Q1 |
2020-03-03 | - | Extra Bolagsstämma 2020 |
2020-02-14 | - | Bokslutskommuniké 2019 |
2019-11-14 | - | Kvartalsrapport 2019-Q3 |
2019-08-15 | - | Kvartalsrapport 2019-Q2 |
2019-05-08 | - | Årsstämma |
2019-05-08 | - | Kvartalsrapport 2019-Q1 |
2019-02-08 | - | X-dag ordinarie utdelning CALTX 0.00 SEK |
2019-02-07 | - | Bokslutskommuniké 2018 |
2018-11-01 | - | Kvartalsrapport 2018-Q3 |
2018-08-16 | - | Kvartalsrapport 2018-Q2 |
Beskrivning
Land | Sverige |
---|---|
Lista | Mid Cap Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
Nasdaq Stockholm has decided that Calliditas Therapeutics AB (publ) will be delisted from Nasdaq Stockholm. The last day of trading in the share will be on Thursday, October 10, 2024.
For further information, please contact:
Åsa Hillsten, Head of IR & Sustainability, Calliditas
Tel.: +46 76 403 35 43, Email: asa.hillsten@calliditas.com
The information was sent for publication, through the agency of the contact person set out above, on September 16, 2024 at 15:30 CET.
About Calliditas
Calliditas Therapeutics is a biopharma company headquartered in Stockholm, Sweden, focused on identifying, developing, and commercializing novel treatments in orphan indications with significant unmet medical needs. Calliditas' common shares are listed on Nasdaq Stockholm (ticker: CALTX). Visit Calliditas.com for further information.